CLINICAL_TRIALS
trial_result
· 2012-12-20
Clinical Trial Update: Trial of Romidepsin and Bortezomib for Multiple Myeloma [Phase 2]
Summary
Phase 2 trial of romidepsin plus bortezomib in multiple myeloma was terminated; results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2012-12-20